jintropin

Calendar

January 2011
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Pages

Archives

Recent Posts

Blogroll






 

Article Date: 14 Sep 2010 – 1:00 PDT

Patients with early-stage schizophrenia who receive a combination of medication and a psychosocial intervention appear less likely to discontinue treatment or relapse-and may have improved insight, quality of life and social functioning-than those taking medication alone, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Antipsychotic drugs are the mainstay of therapy for patients with schizophrenia, but long-term therapy is associated with adverse effects and poor adherence, according to background information in the article. “Most patients, even those with a good response to medication, continue to experience disabling residual symptoms, impaired social and occupational functioning and a high rate of relapse,” the authors write. “Adding psychosocial treatment may produce greater improvements in functional outcome than does medication treatment alone.”

Xiaofeng Guo, M.D., and Jinguo Zhai, M.D., of Second Xiangya Hospital, Central South University, Hunan, China, and colleagues evaluated this combination of therapies in 1,268 patients with early-stage schizophrenia treated from Jan. 1, 2005, through Oct. 31, 2007. A total of 633 were randomly assigned to receive pharmacotherapy plus a psychosocial intervention involving 48 one-hour group sessions. The intervention included four evidence-based practices: psychoeducation (instruction for families and caregivers about mental illness), family intervention (teaching coping and socializing skills), skills training and cognitive behavioral therapy. The other 635 patients received medication alone.

Rates of treatment discontinuation or change were 32.8 percent in the combined treatment group, compared with 46.8 percent in the medication-only group. The risk of relapse was lower among patients in the combination group, occurring in 14.6 percent of patients in that group and 22.5 percent of patients in the medication-only group.

The combined treatment group also exhibited greater improvements in insight, social functioning, activities of daily living and on four domains of quality of life, and a significantly higher proportion of them were employed or received education. There were no significant differences in either frequency or type of adverse events between the groups.

Read in Full:  http://www.medicalnewstoday.com/articles/200886.php

 

What Is Paranoid Schizophrenia? What Causes Paranoid Schizophrenia?
23 Jun 2010
Paranoid schizophrenia is a schizophrenia subtype in which the patient has false beliefs (delusions) that somebody or some people are plotting against them or members of their family…
 

What Is Schizoaffective Disorder? What Causes Schizoaffective Disorder?
02 Jun 2010
 

What Is Catatonic Schizophrenia? What Causes Catatonic Schizophrenia?
19 Jun 2010
 

Discovery Of Gene Linked To Schizophrenia
14 Apr 2010

What Is Childhood Schizophrenia? What Causes Childhood Schizophrenia?
17 Jun 2010



Leave a Reply

*